Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 13, 2014 - Issue 1
Submit an article Journal homepage
552
Views
4
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Adverse effects of golimumab in the treatment of rheumatologic diseases

Hong YangUniversity of California, Division of Rheumatology, Allergy and Immunology, 9500 Gilman Drive, MC 0943, La Jolla, CA, 92093-0943, [email protected]
, MD PhD &
Arthur KavanaughUniversity of California, Division of Rheumatology, Allergy and Immunology, 9500 Gilman Drive, MC 0943, La Jolla, CA, 92093-0943, [email protected]
, MD
Pages 103-112 | Published online: 28 Aug 2013

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Andrea Matucci, Daniele Cammelli, Fabrizio Cantini, Delia Goletti, Valentina Marino, Giuseppe Maria Milano, Raffaele Scarpa, Giuliano Tocci, Enrico Maggi & Alessandra Vultaggio. (2016) Influence of anti-TNF immunogenicity on safety in rheumatic disease: a narrative review. Expert Opinion on Drug Safety 15:sup1, pages 3-10.
Read now
Elisabeth Lippert, Martina Müller & Claudia Ott. (2014) Golimumab in unresponsive ulcerative colitis. Biologics: Targets and Therapy 8, pages 207-210.
Read now

Articles from other publishers (2)

Atul A. Deodhar, Natalie J. Shiff, Cinty Gong, Elizabeth C. Hsia, Kim Hung Lo, Lilliane Kim, Stephen Xu & John D. Reveille. (2022) Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study. JCR: Journal of Clinical Rheumatology 28:5, pages 270-277.
Crossref
Srinivasa Reddy Bonam, Fengjuan Wang & Sylviane Muller. (2018) Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option. Journal of Autoimmunity 94, pages 16-32.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.